Sarah Stenzel is currently a Principal Scientist II in Analytical Operations at Gilead Sciences, where they focus on developing, optimizing, and validating cell-based potency assays to support analytical characterization of novel protein therapeutics. They previously held roles at Gilead Sciences including Associate Scientist II and Senior Research Scientist positions. Sarah also gained experience at MedImmune and the National Institutes of Health, where they contributed to pre-clinical potency sciences and received a prestigious fellowship. They earned a Bachelor of Science from the University of Notre Dame and a Master of Science from The Johns Hopkins University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices